Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.
Southern California College of Optometry at Marshall B. Ketchum University, Fullerton, California.
Ophthalmology. 2019 Sep;126(9):1249-1260. doi: 10.1016/j.ophtha.2019.01.015. Epub 2019 Jan 26.
To describe the course of intermittent exotropia (IXT) in children followed up without treatment for 3 years.
Observation arm from randomized trial of short-term occlusion versus observation.
One hundred eighty-three children 3 to 10 years of age with previously untreated IXT and 400 seconds of arc (arcsec) or better near stereoacuity.
Participants were to receive no treatment unless deterioration criteria were met at a follow-up visit occurring at 3 months, 6 months, or 6-month intervals thereafter for 3 years.
The primary outcome was deterioration by 3 years, defined as meeting motor criterion (constant exotropia ≥10 prism diopters [Δ] at distance and near) or near stereoacuity criterion (≥2-octave decrease from best previous measure). For the primary analysis, participants also were considered to have deteriorated if treatment was prescribed without meeting either deterioration criterion.
The cumulative probability of protocol-specified deterioration by 3 years was 15% (95% confidence interval, 10%-22%), but that was likely an overestimate, partly because of misclassification. Among 25 deteriorations, 2 met motor deterioration, 11 met stereoacuity deterioration, and 12 started treatment without meeting either criteria (7 for social concern, 1 for diplopia, 4 for other reasons). Among the 132 participants who completed the 3-year visit and had not been treated during the study, only 1 (<1%) met motor or stereoacuity deterioration criteria at 3 years. Of the 4 participants completing the 3-year visit who met deterioration criteria previously and had not started treatment, none still met deterioration criteria. Between the baseline and 3-year examination for these 132 patients, improvement occurred in distance and near stereoacuity (mean improvement, 0.14 and 0.14 logarithm of arcsec; P ≤ 0.001 and P ≤ 0.001, respectively), distance exotropia control (mean improvement, 0.6 points; P ≤ 0.001), and distance exodeviation magnitude (mean improvement, 2.2 Δ; P = 0.002).
Among children 3 to 10 years of age with IXT for whom surgery was not considered to be the immediately necessary treatment, stereoacuity deterioration or progression to constant exotropia over 3 years was uncommon, and exotropia control, stereoacuity, and magnitude of deviation remained stable or improved slightly.
描述未经治疗的间歇性外斜视(IXT)患儿 3 年的病程。
短期遮盖治疗与观察的随机试验的观察臂。
183 名年龄在 3 至 10 岁之间的儿童,这些儿童患有未经治疗的间歇性外斜视,并且近立体视锐度在 400 弧秒(arcsec)或更好。
参与者在 3 个月、6 个月或此后每 6 个月进行一次随访,如果符合恶化标准,除非接受治疗,否则将在 3 年内进行治疗。
主要结果为 3 年内的恶化,定义为符合运动标准(在距离和近距处的恒定外斜视≥10 棱镜度[Δ])或近立体视锐度标准(与之前最佳测量值相比,下降≥2 个 octave)。对于主要分析,如果未达到任何恶化标准就开具治疗处方,则认为参与者也出现了恶化。
通过 3 年时间,符合方案规定的恶化的累积概率为 15%(95%置信区间,10%-22%),但这可能是高估了,部分原因是分类错误。在 25 例恶化中,2 例符合运动恶化标准,11 例符合立体视锐度恶化标准,12 例在未符合任何标准的情况下开始治疗(7 例为社交原因,1 例为复视,4 例为其他原因)。在 132 名完成 3 年随访且在研究期间未接受治疗的参与者中,只有 1 名(<1%)在 3 年内符合运动或立体视锐度恶化标准。在之前达到恶化标准但未开始治疗的 4 名完成 3 年随访的参与者中,没有一人仍符合恶化标准。在这些 132 名患者的基线和 3 年检查之间,距离和近距立体视锐度(平均改善 0.14 和 0.14 对数弧秒;P≤0.001 和 P≤0.001)、距离外斜视控制(平均改善 0.6 点;P≤0.001)和距离外斜视程度(平均改善 2.2Δ;P=0.002)均有所改善。
对于 3 至 10 岁的 IXT 患儿,如果手术不是首选的治疗方法,3 年内立体视锐度恶化或进展为恒定性外斜视并不常见,斜视控制、立体视锐度和斜视程度仍保持稳定或略有改善。